Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma

Annals of Oncology

Volumn 15, Issue 9, 2004, Pages 1432-1438

  Yamamoto, S ^a   Tomita, Y ^a   Hoshida, Y ^a   Toyosawa, S ^b   Inohara, H ^a   Kishino, M ^b   Kogo, M ^b   Nakazawa, M ^b   Murakami, S ^b   Iizuka, N ^a   Kidogami, S ^a   Monden, M ^a   Kubo, T ^a   Ijuhin, N ^b   Aozasa, K ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Gingival squamous cell cancer; Prognosis; Valosin containing protien

Indexed keywords

CISPLATIN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P97;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; FEMALE; GINGIVA TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

EID: 4644275079     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh354     Document Type: Article

References (18)

1. Parkin DM, Whelan S, Ferlay JL et al. Cancer incidence in five continents: vol VII. Lyon, France: International Agency for Research on Cancer 1997.
2. Gomez D, Faucher A, Picot V et al. Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg 2000; 28: 331-335.
3. Yokoo S, Umeda M, Komatsubara H et al. Evaluation of T-classifications of upper gingival and hard palate carcinomas - a proposition for new criterion of T4. Oral Oncol 2002; 38: 378-382.
4. Sobin LH, Wittekind CH. TNM classification of malignant tumours, 6th edition. New York, NY: Wiley-Liss 2002.
5. Asai T, Tomita Y, Nakatsuka S et al. VCP (p97) Regulates NF-kappaB Signaling Pathway, Which Is Important for Metastasis of Osteosarcoma Cell Line. Jpn J Cancer Res 2002; 93: 296-304.
6. Dai RM, Chen E, Longo DL et al. Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 1998; 273: 3562-3573.
7. Yamamoto S, Tomita Y, Nakamori S et al. Elevated Expression of Valosin-Containing Protein (p97) in Hepatocellular Carcinoma Is Correlated With Increased Incidence of Tumor Recurrence. J Clin Oncol 2003; 21: 447-452.
8. Yamamoto S, Tomita Y, Hoshida Y et al. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 2003; 21: 2537-2544.
9. Tsujimoto Y, Tomita Y, Hoshida Y et al. Elevated expression of Valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 2004; 10: 3007-3012.
10. Muller JM, Meyer HH, Ruhrberg C et al. The mouse p97 (CDC48) gene. Genomic structure, definition of transcriptional regulatory sequences, gene expression, and characterization of a pseudogene. J Biol Chem 1999; 274: 10154-10162.
11. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34: 187-220.
13. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 2000; 36: 404-413.
14. Brennan JA, Boyle JO, Koch WM et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-717.
15. Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000; 1470: M55-M62.
16. Andela VB, Schwarz EM, Puzas JE et al. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 2000; 60: 6557-6562.
17. Chen S, Fribley A, Wang CY. Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-kappaB inhibitor. J Dent Res 2002; 81: 98-102.
18. Duffey DC, Chen Z, Dong G et al. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999; 59: 3468-3474.